Epidiolex Showing Promise?


Results of 3 uncontrolled studies of Epidiolex seem to show promise for patients with epilepsy.  Here’s an excerpt and summary of Epidiolex results released yesterday at the American Epilepsy Society meeting.  As the researchers caution, these were uncontrolled studies, and more research is required via clinical trials due to conclude in about 6 months.  This is great news for those children and their families who are suffering from debilitating seizures!

This is also key for states to see this news and to put their plans on hold to legalize marijuana for medical purposes.  As these clinical trial results get released, there likely will not be a need for states to take matters into their own hands any longer, as the FDA may be approving some actual medicine for these conditions.

“After three months of treatment, the frequency of all seizures was reduced by a median of 45 percent in all participants. Almost half (47%) of the participants in the study experienced a 50 percent or greater reduction in seizures and nine percent of patients were seizure-free. Among specific patient populations, DS (Dravet Syndrome) patients had a 62 percent reduction in seizures and 13 percent were seizure-free. Patients with LGS (Lennox-Gastaut Syndrome) experienced a 71 percent reduction in atonic seizures.”



© Copyright Prevention Means Progress - Website Design by REBEL INTERACTIVE